P-Glycoprotein System As a Determinant of Drug Interactions: The Case of Digoxin–verapamil

Author： Verschraagen M. Koks C.H.W. Schellens J.H.M. Beijnen J.H.

ISSN： 1043-6618

Source： Pharmacological Research, Vol.40, Iss.4, 1999-10, pp. : 301-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe Schmitz Volker Haschke Manuel

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite

The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions

By DuBuske Lawrence M.

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 789-801

Adis International

Access to resources Recommend Favorite

Loxapine P-glycoprotein Interactions In Vitro

Drug Metabolism Letters, Vol. 6, Iss. 1, 2012-01 ,pp. : 26-32

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite